 Analysis of prognostic factors of 160 cases with epithelial ovarian cancer.

DU Jun-yao*,DU Zhen-guang,CHANG Lu,RAO Jun,LI Lian-kun*.

Chinese Journal of Practical Gynecology and Obstetrics ›› 2014, Vol. 30 ›› Issue (6) : 475-478.

Chinese Journal of Practical Gynecology and Obstetrics ›› 2014, Vol. 30 ›› Issue (6) : 475-478. DOI: 10.7504/fk2014050121

 Analysis of prognostic factors of 160 cases with epithelial ovarian cancer.

  • DU Jun-yao*,DU Zhen-guang,CHANG Lu,RAO Jun,LI Lian-kun*.
Author information +
History +

Abstract

Abstract:Objective To assess prognostic factors impacted on overall survival in patients with epithelial ovarian carcinoma.Methods Totally 160 patients with stages I-IV epithelial ovarian carcinoma admitted in Liao-ning Provincial Cancer Hospital from Jan. 2006 to Dec. 2007 were analyzed by retrospective analysis.Results The prognosis of epithelial ovarian carcinomas were related to the number of labors,stage, peritoneal metastasis, the size of residues lesions, the number of courses of chemotherapy, sensitivity to platinum and the level of CA125 after 2-3 courses of chemotherapy (P<0.05).Compared with stage Ⅳ, the risk of mortality was 0.164 for stage Ⅰ(95%CI 0.035-0.775),0.175 for stage Ⅱ(95%CI 0.037-0.820),0.359 (95%CI 0.184-0.704 ) for stage Ⅲ ([WTBX]P[WTBZ]<0.05). The risk of mortality was 0.368,(95%CI 0.209~0.647) for the patients received ≥6 courses of chemotherapy,in comparison with patients received <6 courses of chemotherapy(P<0.01).The risk of mortality in the patients insensitive to platinum was 4.434 times higher than that in patients sensitive to platinum (95%CI 2.454-8.012, P<0.01). The risk of mortality in the patients of serum CA125>35 kU/L after 2-3 courses of chemotherapy was 2.062 times higher than that in patients CA125≤35 kU/L (95%CI 1.190-3.572,[WTBX]P[WTBZ]=0.01).Conclusion The major independent prognostic factor of epithelial ovarian carcinoma is stage, the number of course of chemotherapy,sensitivity to platinum and the level of CA125 after 2-3 courses of chemotherapy.

Key words

ovarian cancer / prognosis / survival rate of five years

Cite this article

Download Citations
DU Jun-yao*,DU Zhen-guang,CHANG Lu,RAO Jun,LI Lian-kun*..  Analysis of prognostic factors of 160 cases with epithelial ovarian cancer.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2014, 30(6): 475-478 https://doi.org/10.7504/fk2014050121

References

[1] 连利娟.林巧稚妇科肿瘤学[M].4版.北京:人民卫生出版社,2006:580.


[2] Bell J,Brady MF,Young RC, et al. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study[J].Gynecol Oncol,2006,102(3):432-439.


[3] Bertelsen K,Jakobsen A,Str yer J,et al. A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA) [J].Gynecol Oncol,1993,49(1):30-36.


[4] 黄永文,李玉洁,李孟达.Ⅱ~Ⅳ期上皮性卵巢癌术后化疗方案选择和疗程优化的探讨[J].癌症,2005,24(8):994-997.


[5] 黄啸,蔡树模,汤洁,等.综合性治疗复发性卵巢癌上皮性癌的疗效及预后分析[J].中华妇产科杂志,2004,39:602-605.


[6] Iwase H, Takada T, Iitsuka C, et al.Clinical features of long-term survivors of recurrent epithelial ovarian cancer[J].Int J Clin Oncol,2014,Mar 26. [Epub ahead of print]


[7] 周慧梅,黄慧芳,潘凌亚,等.血清CA125值的变化对判断上皮性卵巢癌疗效及预后的临床研究[J].中国实用妇科与产科杂志,2008,24(3):204-206.


[8] Van Altena AM,Kolwijck E,Spanjer MJ,et al.CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study[J].Gynecol Oncol,2010,119(2):265-269. 

Accesses

Citation

Detail

Sections
Recommended

/